KCB-1 protein, recombinant

Known as: recombinant human basic fibroblast growth factor 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2017
012319882017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Controlled delivery of multiple therapeutic agents can be considered as an effective approach in skin tissue engineering. In this… (More)
Is this relevant?
2012
2012
The incidence of after-cataracts [also known as posterior capsular opacification (PCO)] is between 30% and 50% three years… (More)
  • table 1
  • table 2
Is this relevant?
2007
2007
Site-specific controlled release of biologically active angiogenic growth factors such as recombinant human basic fibroblast… (More)
Is this relevant?
2007
2007
Recombinant human basic fibroblast growth factor (rhbFGF) is a peptide with many bioactivities such as promoting proliferation… (More)
Is this relevant?
2006
2006
BACKGROUND The healing period of bone-implant osseointegration usually varies from 3 to 6 months or even longer. Failure may… (More)
Is this relevant?
2005
2005
We report the use of topical application of recombinant human basic fibroblast growth factor (rhbFGF) to successfully treat… (More)
Is this relevant?
2005
2005
Local angiogenic therapy with recombinant human basic fibroblast growth factor (rhbFGF) has been used to promote wound healing… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The effect of local application of recombinant human basic fibroblast growth factor (rhbFGF) on fracture repair was examined… (More)
Is this relevant?
1994
1994
We examined the in vitro effects of pituitary-derived chicken growth hormone (cGH), recombinant human insulin-like growth factor… (More)
Is this relevant?
1991
1991
Recombinant human basic fibroblast growth factor (rhbFGF) was found to induce secretion of nerve growth factor (NGF) in cultured… (More)
Is this relevant?